Scientists at Rutgers University–Newark have developed a first-of-its-kind RNA-based nanotechnology that assembles itself inside living human cells and can be programmed to stop propagation of harmful ...

Technology created at the University of Queensland could improve the odds of surviving brain cancer and change how we treat a range of neurological conditions. Dr. Richard Lobb and Dr. Zhen Zhang from ...

First, we pretrained the encoder of a transformer-based network using a self-supervised approach on unlabeled abdominal computed tomography images. Subsequently, we fine-tuned the segmentation network ...

As shown below, the inferred masks predicted by our segmentation model trained by the dataset appear similar to the ground truth masks. This repository contains a curated and enhanced version of brain ...

Drinking alcohol is linked to higher chances of colorectal cancer − but just how many drinks increase your risk? New research, published Jan. 26 in the American Cancer Society's peer-reviewed journal ...

Woody the dog required complex brain surgery at DoveLewis Veterinary Emergency & Specialty Hospital in Portland to treat his multilobular osteochondrosarcoma Kelli Bender is the Pets Editor at PEOPLE.

WASHINGTON – Health and Human Services Secretary Robert F. Kennedy Jr. told USA TODAY that “electromagnetic radiation is a major health concern” a day after his department launched a study of ...

UW-Madison researchers have found potential new treatments for a rare pediatric brain cancer each year that has a median survival time of less than a year. The research involved thousands of fruit ...

ORANGE, Calif. (KABC) -- If radiologists can catch a breast tumor when it's two centimeters or less, doctors say the cure rate is 90 percent. Providence St. Joseph Hospital in Orange is pairing ...

Scientists at MIT and Stanford have unveiled a promising new way to help the immune system recognize and attack cancer cells more effectively. Their strategy targets a hidden “off switch” that tumors ...

Hormone replacement therapy (HRT) does not increase breast cancer risk in BRCA1/BRCA2 carriers, with estrogen-alone formulations showing a lower risk. The study used a matched-pair design to control ...